vs

Side-by-side financial comparison of Penumbra Inc (PEN) and Upstart Holdings, Inc. (UPST). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $296.1M, roughly 1.3× Upstart Holdings, Inc.). Penumbra Inc runs the higher net margin — 12.3% vs 6.3%, a 6.0% gap on every dollar of revenue. On growth, Upstart Holdings, Inc. posted the faster year-over-year revenue change (35.2% vs 22.1%). Upstart Holdings, Inc. produced more free cash flow last quarter ($108.4M vs $68.0M). Over the past eight quarters, Upstart Holdings, Inc.'s revenue compounded faster (52.2% CAGR vs 17.6%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

Upstart is an AI lending platform that partners with banks and credit unions to provide consumer loans using non-traditional variables, such as education and employment, to predict creditworthiness.

PEN vs UPST — Head-to-Head

Bigger by revenue
PEN
PEN
1.3× larger
PEN
$385.4M
$296.1M
UPST
Growing faster (revenue YoY)
UPST
UPST
+13.1% gap
UPST
35.2%
22.1%
PEN
Higher net margin
PEN
PEN
6.0% more per $
PEN
12.3%
6.3%
UPST
More free cash flow
UPST
UPST
$40.3M more FCF
UPST
$108.4M
$68.0M
PEN
Faster 2-yr revenue CAGR
UPST
UPST
Annualised
UPST
52.2%
17.6%
PEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PEN
PEN
UPST
UPST
Revenue
$385.4M
$296.1M
Net Profit
$47.3M
$18.6M
Gross Margin
68.0%
Operating Margin
15.4%
6.4%
Net Margin
12.3%
6.3%
Revenue YoY
22.1%
35.2%
Net Profit YoY
40.6%
776.4%
EPS (diluted)
$1.20
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
UPST
UPST
Q4 25
$385.4M
$296.1M
Q3 25
$354.7M
$277.1M
Q2 25
$339.5M
$257.3M
Q1 25
$324.1M
$213.4M
Q4 24
$315.5M
$219.0M
Q3 24
$301.0M
$162.1M
Q2 24
$299.4M
$127.6M
Q1 24
$278.7M
$127.8M
Net Profit
PEN
PEN
UPST
UPST
Q4 25
$47.3M
$18.6M
Q3 25
$45.9M
$31.8M
Q2 25
$45.3M
$5.6M
Q1 25
$39.2M
$-2.4M
Q4 24
$33.7M
$-2.8M
Q3 24
$29.5M
$-6.8M
Q2 24
$-60.2M
$-54.5M
Q1 24
$11.0M
$-64.6M
Gross Margin
PEN
PEN
UPST
UPST
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Q1 24
65.0%
Operating Margin
PEN
PEN
UPST
UPST
Q4 25
15.4%
6.4%
Q3 25
13.8%
8.5%
Q2 25
12.0%
1.8%
Q1 25
12.4%
-2.1%
Q4 24
13.6%
-2.2%
Q3 24
11.7%
-27.8%
Q2 24
-27.0%
-43.5%
Q1 24
4.3%
-52.8%
Net Margin
PEN
PEN
UPST
UPST
Q4 25
12.3%
6.3%
Q3 25
12.9%
11.5%
Q2 25
13.3%
2.2%
Q1 25
12.1%
-1.1%
Q4 24
10.7%
-1.3%
Q3 24
9.8%
-4.2%
Q2 24
-20.1%
-42.7%
Q1 24
3.9%
-50.5%
EPS (diluted)
PEN
PEN
UPST
UPST
Q4 25
$1.20
$0.20
Q3 25
$1.17
$0.23
Q2 25
$1.15
$0.05
Q1 25
$1.00
$-0.03
Q4 24
$0.88
$-0.01
Q3 24
$0.75
$-0.07
Q2 24
$-1.55
$-0.62
Q1 24
$0.28
$-0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
UPST
UPST
Cash + ST InvestmentsLiquidity on hand
$186.9M
$652.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$798.8M
Total Assets
$1.8B
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
UPST
UPST
Q4 25
$186.9M
$652.4M
Q3 25
$321.0M
$489.8M
Q2 25
$421.8M
$395.9M
Q1 25
$376.1M
$599.8M
Q4 24
$324.4M
$788.4M
Q3 24
$280.5M
Q2 24
$288.3M
Q1 24
$223.1M
Stockholders' Equity
PEN
PEN
UPST
UPST
Q4 25
$1.4B
$798.8M
Q3 25
$1.4B
$743.7M
Q2 25
$1.3B
$722.0M
Q1 25
$1.2B
$676.6M
Q4 24
$1.2B
$633.2M
Q3 24
$1.1B
$595.5M
Q2 24
$1.2B
$594.7M
Q1 24
$1.2B
$612.8M
Total Assets
PEN
PEN
UPST
UPST
Q4 25
$1.8B
$3.0B
Q3 25
$1.7B
$2.9B
Q2 25
$1.7B
$2.5B
Q1 25
$1.6B
$2.3B
Q4 24
$1.5B
$2.4B
Q3 24
$1.5B
$1.8B
Q2 24
$1.5B
$1.8B
Q1 24
$1.6B
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
UPST
UPST
Operating Cash FlowLast quarter
$86.5M
$108.6M
Free Cash FlowOCF − Capex
$68.0M
$108.4M
FCF MarginFCF / Revenue
17.7%
36.6%
Capex IntensityCapex / Revenue
4.8%
0.1%
Cash ConversionOCF / Net Profit
1.83×
5.82×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
UPST
UPST
Q4 25
$86.5M
$108.6M
Q3 25
$58.3M
$-122.6M
Q2 25
$44.9M
$-120.2M
Q1 25
$49.0M
$-13.5M
Q4 24
$51.1M
$-110.9M
Q3 24
$56.5M
$179.3M
Q2 24
$22.6M
$65.3M
Q1 24
$38.3M
$52.6M
Free Cash Flow
PEN
PEN
UPST
UPST
Q4 25
$68.0M
$108.4M
Q3 25
$42.0M
$-122.7M
Q2 25
$29.4M
$-120.3M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
$179.2M
Q2 24
$18.1M
$65.3M
Q1 24
$32.5M
$51.9M
FCF Margin
PEN
PEN
UPST
UPST
Q4 25
17.7%
36.6%
Q3 25
11.8%
-44.3%
Q2 25
8.7%
-46.7%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
110.5%
Q2 24
6.0%
51.1%
Q1 24
11.7%
40.6%
Capex Intensity
PEN
PEN
UPST
UPST
Q4 25
4.8%
0.1%
Q3 25
4.6%
0.0%
Q2 25
4.6%
0.0%
Q1 25
4.2%
0.0%
Q4 24
1.7%
0.0%
Q3 24
1.8%
0.1%
Q2 24
1.5%
0.0%
Q1 24
2.1%
0.5%
Cash Conversion
PEN
PEN
UPST
UPST
Q4 25
1.83×
5.82×
Q3 25
1.27×
-3.86×
Q2 25
0.99×
-21.43×
Q1 25
1.25×
Q4 24
1.52×
Q3 24
1.91×
Q2 24
Q1 24
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

UPST
UPST

Personal Lending Segment$201.4M68%
Servicing Fees Net$39.5M13%
Servicing Fees$27.5M9%
Other$15.7M5%
Borrower Fees$8.4M3%
Collection Agency Fees$3.5M1%

Related Comparisons